Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria
- PMID: 19203667
- DOI: 10.1016/j.jaci.2008.11.043
Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria
Comment in
-
Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies.J Allergy Clin Immunol. 2011 Dec;128(6):1354-5. doi: 10.1016/j.jaci.2011.08.023. Epub 2011 Sep 28. J Allergy Clin Immunol. 2011. PMID: 21958584 No abstract available.
Comment on
-
Treatment of chronic autoimmune urticaria with omalizumab.J Allergy Clin Immunol. 2008 Sep;122(3):569-73. doi: 10.1016/j.jaci.2008.07.006. J Allergy Clin Immunol. 2008. PMID: 18774392 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
